Biomea Fusion (BMEA)
Develops oral small-molecule medicines for diabetes and obesity.
$1.39
vs last close−0.31 (−18.53%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 34.84% | 25.25M shares | |
|---|---|---|---|
| 65 holders · as of Jun 30, 2026 | |||
| Insiders | 2.78% | 2.02M shares | |
| 3 holders · as of Feb 6, 2026 | |||
| Strategic holders | 16.00% | 11.60M shares | |
| 2 holders · as of Feb 17, 2026 | |||
| Other | 46.38% | 33.62M shares | |
| remainder | |||
72.48M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
65 holders · 25.25M shares · 10 new positions · 33 increased · 8 reduced · 14 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 8.81M | 12.16% | +1.6K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 2.83M | 3.90% | +232.6K | Aug 13, 2026 |
| Marshall Wace, LLP | 2.05M | 2.83% | +851.3K | Aug 13, 2026 |
| Aisling Capital Management LP | 2.05M | 2.83% | 0 | Aug 13, 2026 |
| Renaissance Technologies LLC | 1.46M | 2.01% | +142.7K | Aug 13, 2026 |
| Fideuram - Intesa Sanpaolo Private Banking S.P.A. | 723.2K | 1.00% | +166.1K | Jul 23, 2026 |
| BlackRock, Inc. | 715.4K | 0.99% | +74.0K | Aug 7, 2026 |
| Geode Capital Management, LLC | 708.9K | 0.98% | +160.7K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| CVI Investments, Inc. | 9.90% | 7.85M | 13G | Feb 17, 2026 |
| Blue Owl Capital Holdings LP | 5.92% | 4.45M | 13G | Feb 12, 2026 |
| Janus Henderson Group PLC | 5.00% | 3.75M | 13G | Dec 8, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 11, 2025 | Rainer M. Erdtmanndirector, officer: See Remarks | Purchase | 30,000 | $1.43 | 723,027 |
| Dec 2, 2025 | Michael J.M. Hitchcockdirector, officer: Interim CEO | Purchase | 100,000 | $0.9918 | 115,000 |
| Nov 28, 2025 | Rainer M. Erdtmanndirector, officer: See Remarks | Purchase | 40,000 | $1.10 | 683,027 |
| Dec 1, 2025 | Rainer M. Erdtmanndirector, officer: See Remarks | Purchase | 10,000 | $1.05 | 693,027 |
House and Senate disclosures
Not reported.